Wilfret, D. A., Walker, J., Adkison, K. K., Jones, L. A., Lou, Y., Gan, J., . . . Spreen, W. (2013). Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1. American Society for Microbiology.
Chicago-tyylinen lähdeviittausWilfret, D. A., et al. Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected With HCV Genotype 1. American Society for Microbiology, 2013.
MLA-viiteWilfret, D. A., et al. Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected With HCV Genotype 1. American Society for Microbiology, 2013.